Superworth

Healthcare stocks with the fastest expected revenue growth

Analysts' consensus revenue for the next four quarters against the last four reported. As of .

Ranked
53
of 874 healthcare stocks we cover
Median
+5.0%
Highest
+113.1%
INSM
Range
−12.3% to +113.1%
median +5.0%
−6.0%+48.3%
#CompanyExpected growthRevenue growth (TTM)Forward PEMarket cap
1INSMInsmed, Biotechnology+113.1%+185.8%n/m$23.7B
2WATWaters, Medical - Diagnostics & Research+48.3%+52.5%30.4×$46.4B
3RPRXRoyalty Pharma, Medical - Pharmaceuticals+37.2%+10.0%13.6×$38.7B
4ALNYAlnylam Pharmaceuticals, Biotechnology+32.3%+95.1%18.9×$21.2B
5GHGuardant Health, Medical - Diagnostics & Research+31.1%+42.7%n/m$23.7B
6REGNRegeneron Pharmaceuticals, Biotechnology+20.4%+9.3%15.1×$100B
7ONCBeOne Medicines, Biotechnology+17.8%+34.3%45.0×$40.2B
8NTRANatera, Medical - Diagnostics & Research+15.6%+37.8%n/m$56.2B
9LLYEli Lilly and, Drug Manufacturers - General+14.9%+45.5%30.9×$1.3T
10HUMHumana, Medical - Healthcare Plans+13.7%+18.3%33.0×$49.5B
11ISRGIntuitive Surgical, Medical - Instruments & Supplies+12.1%+20.5%36.2×$154.6B
12DXCMDexCom, Medical - Devices+10.6%+15.5%30.0×$31.9B
13VRTXVertex Pharmaceuticals, Biotechnology+10.6%+10.5%27.9×$137.1B
14SYKStryker, Medical - Devices+9.7%+8.5%19.4×$118.6B
15ABBVAbbVie, Drug Manufacturers - General+9.1%+10.7%18.3×$511.6B
16DHRDanaher, Medical - Diagnostics & Research+8.9%+5.5%25.4×$162.6B
17EWEdwards Lifesciences, Medical - Devices+8.5%+14.6%30.1×$54.6B
18IDXXIDEXX Laboratories, Medical - Diagnostics & Research+7.6%+12.8%42.4×$52.1B
19STESTERIS, Medical - Specialties+7.2%+8.4%20.2×$22.7B
20AAgilent Technologies, Medical - Diagnostics & Research+6.7%+8.6%26.8×$49.6B
21MCKMcKesson, Medical - Distribution+6.6%+8.8%21.5×$116.5B
22JNJJohnson & Johnson, Drug Manufacturers - General+6.5%+7.8%23.9×$650.2B
23ILMNIllumina, Medical - Diagnostics & Research+5.6%+4.9%41.5×$35.7B
24IQVIQVIA, Medical - Diagnostics & Research+5.5%+8.2%19.0×$42.5B
25AMGNAmgen, Drug Manufacturers - General+5.3%+9.1%19.8×$252.3B
26LHLabcorp, Medical - Diagnostics & Research+5.2%+6.4%18.8×$28.9B
27GILDGilead Sciences, Drug Manufacturers - General+5.0%+6.5%19.8×$212.5B
28BIIBBiogen, Drug Manufacturers - General+5.0%+0.3%19.0×$37B
29TMOThermo Fisher Scientific, Medical - Diagnostics & Research+5.0%+8.3%25.8×$256.9B
30MTDMettler-Toledo International, Medical - Diagnostics & Research+4.7%+6.9%34.6×$34.2B
31CORCencora, Medical - Distribution+4.5%+5.1%17.4×$64.4B
32CAHCardinal Health, Medical - Distribution+4.5%+14.2%20.3×$59.2B
33GEHCGE HealthCare Technologies, Medical - Devices+4.2%+6.5%15.4×$36B
34MDTMedtronic, Medical - Devices+4.2%+9.8%16.5×$126.7B
35CICigna, Medical - Healthcare Plans+3.8%+7.8%9.3×$77.8B
36WSTWest Pharmaceutical Services, Medical - Instruments & Supplies+2.7%+12.4%44.2×$28.9B
37RMDResMed, Medical - Instruments & Supplies+2.6%+9.9%18.4×$32.3B
38BSXBoston Scientific, Medical - Devices+2.4%+13.5%13.4×$63B
39THCTenet Healthcare, Medical - Care Facilities+2.3%+5.4%12.8×$21.5B
40HCAHCA Healthcare, Medical - Care Facilities+2.3%+7.3%15.2×$100.9B
41UNHUnitedHealth, Medical - Healthcare Plans+1.8%+3.3%17.6×$356.9B
42CVSCVS Health, Medical - Healthcare Plans+1.7%+7.4%10.9×$113.7B
43INCYIncyte, Biotechnology+1.6%+26.9%51.3×$24.3B
44MRKMerck, Drug Manufacturers - General+0.8%+4.9%17.2×$359.5B
45UTHRUnited Therapeutics, Biotechnology+0.6%+2.5%22.6×$25.9B
46ELVElevance Health, Medical - Healthcare Plans−1.0%+6.3%15.1×$89.7B
47BMYBristol-Myers Squibb, Drug Manufacturers - General−2.5%+4.2%9.8×$128.7B
48ZTSZoetis, Drug Manufacturers - Specialty & Generic−2.8%+1.5%13.4×$34.3B
49PFEPfizer, Drug Manufacturers - General−4.2%−0.2%11.2×$176B
50TEVATeva Pharmaceutical Industries, Drug Manufacturers - Specialty & Generic−4.3%+4.1%15.3×$49.7B
51CNCCentene, Medical - Healthcare Plans−5.6%+13.9%14.2×$32.8B
52BDXBecton, Dickinson and, Medical - Instruments & Supplies−6.0%+5.2%15.0×$54B
53MRNAModerna, Biotechnology−12.3%−27.6%n/m$92.1B

Not ranked: 705 with not a meaningful number, 1 with expected growth from a base too small to compare, 1 with no revenue estimates. 114 companies whose data behind this number has a caveat are left out until it is checked.

A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.

Expected growth for other groups

Other rankings of healthcare stocks

The group